drugset / Trial / NCT00326027

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

NCT00326027

Phase 3 Completed 29 enrolled Nycomed
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of the study is to evaluate the effect of pantoprazole on fast symptom reduction in hospitalized patients with NERD (non-erosive reflux disease) or GERD (gastroesophageal reflux disease, Los Angeles \[LA\] Grade A-D). During the study, the patients will complete a patient-orientated, self-assessed reflux questionnaire (ReQuest™). The study duration consists of a treatment period of 7 days ± 3 days. Pantoprazole (tablet) will be administered once daily in the morning to patients with NERD or GERD at one dose level for each indication. The study will provide further data on the safety and tolerability of pantoprazole.

Timeline

Start
2006-10
Primary completion
2007-07
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified 20 mg Oral
Comparator Pantoprazole Other / unclassified 40 mg Oral